Pdb1 - Acute Renal Outcomes With Sodium Glucose Co-Transporter 2 Inhibitors- Real World Data Analysis

Value in Health- United Kingdom

doi 10.1016/j.jval.2018.09.708

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

Sodium–glucose Co-Transporter 2 Inhibitors: Think Twice About Diabetic Ketoacidosis

2018English

Sodium‐glucose Co‐transporter Type‐2 Inhibitors: Is the Message Getting Through?

Anaesthesia
AnesthesiologyPain Medicine
2019English

Sodium-Glucose Co-Transporter Type-2 Inhibitors: Pharmacology and Peri-Operative Considerations

Anaesthesia
AnesthesiologyPain Medicine
2018English

Sodium Glucose Co-Transporter 2 Inhibitors and Cardiovascular Event Protections: How Applicable Are Clinical Trials and Observational Studies to Real-World Patients?

BMJ Open Diabetes Research and Care
EndocrinologyMetabolismDiabetes
2019English

Sodium-Glucose Co-Transporter-2 Inhibitors in Type 1 Diabetes—a Dangerous Ally

US Endocrinology
EndocrinologyMetabolismDiabetes
2017English

Does Gender Influence the Cardiovascular Benefits Observed With Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitors? A Meta-Regression Analysis

Cardiology and Therapy
2016English

Sodium‐glucose Co‐transporter Type‐2 Inhibitors: Is the Message Getting Through? A Reply

Anaesthesia
AnesthesiologyPain Medicine
2019English

Early Effects of Sodium-Glucose Co-Transporter 2 Inhibitors in Type 2 Diabetes: Study Based on Continuous Glucose Monitoring

Diabetology and Metabolic Syndrome
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Sodium-Glucose Co-Transporter 2 Inhibitors: A Review of Their Use in Older People With Type 2 Diabetes Mellitus

Journal of Pharmacy Practice and Research
PharmacologyPharmacy
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy